Munich Cluster for Systems Neurology
print


Breadcrumb Navigation


Content

Curriculum vitae Prof. Dr. Martin Dichgans

    • Date of Birth: May 4, 1966

Training

    • 1987 - 1993 Studies of medicine at the University of Freiburg, Heidelberg, Vienna & Munich
    • 1994 - 2001 Residency in Neurology and Psychiatry
    • 2001 - 2010 Consultant in Neurology

Academic positions & appointments

    • since 2006 Professor of Neurology
    • since 2010 Director Institute of Stroke and Dementia Research, Klinikum der Universität München
    • since 2010 Chair, Stroke and Dementia Research (W3)
    • since 2010 Head, Interdisciplinary Stroke Centre Munich

Research coordination

    • since 2011 Coordinator, Clinical Research, DZNE Munich
    • since 2012 Scientific Board and Research Coordinator, Munich Cluster of Systems Neurology
    • since 2014 Chair, Scientific Advisory Board, ERANET-NEURON, FP7 European Union
    • since 2015 Executive Committee, European Stroke Organization (ESO)
    • since 2016 President, German Stroke Society (DSG) and Board of Directors (since 2014)

Membership in Editorial Boards

    • 2006 - 2010 Section Editor, STROKE (Journal of the American Heart Association)
    • since 2006 Editorial Board Member, STROKE (Journal of the American Heart Association)
    • since 2010 Editorial Board Member, Cerebrovascular Diseeases
    • since 2010 Associate Editor, Frontiers in Stroke
    • 2011 - 2016 Handling Editor J Neurochemistry
    • since 2013 Section Editor Int J Stroke (WSO)
    • since 2015 Section Editor, STROKE (Journal of the American Heart Association)
    • since 2016 Editorial Board European Stroke Journal (ESO)
    • since 2017 Editorial Board Annals of Neurology

Awards & honors

    • 1988 - 1993 Stipend, Bischöfliche Studienförderung, Cusanuswerk
    • 1994 - 1995 Stipend, Ernst Jung-Foundation (Stiftung für Wissenschaft und Forschung)
    • 1997 Award, European Neurological Society (ENS)
    • 1998 Award, European Neurological Society (ENS)
    • 2009 Teaching Award of the Medical Faculty, LMU Munich

10 key papers

    • Malik R, et al. Debette S, Dichgans M. Multi-ancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet doi: 10.1038/s41588-018-0058-3. [Epub ahead of print] (2018)
    • Tiedt S, Prestel M, Malik R, Schieferdecker N, Duering M, Kautzky V, Stoycheva I, Böck J, Northoff BH, Klein M, Dorn F, Krohn K, Teupser D, Liesz A, Plesnila N, Holdt LM, Dichgans M. RNA-Seq identifies circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as potential biomarkers for acute ischemic stroke. Circ Res 121:970-80 (2017)
    • Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black S, Brayne C, Breteler M, Chabriat H, DeCarli C, de Leeuw FE, Doubal F, Duering M, Fox N, Greenberg S, Hachinski V, Kilimann I, Mok V, van Oostenbrugge R, Pantoni L, Speck O, Stephan BCM, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: A united approach. Lancet Neurol 12:822-38 (2013)
    • Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 12:483-97 (2013)
    • Duering M, Csanadi E, Gesierich B, Jouvent E, Hervé D, Seiler S, Belaroussi B, Ropele S, Schmidt R, Chabriat C, Dichgans M. Incident lacunes preferentially localise to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain 136:2717-26 (2013)
    • Freilinger T, Anttila V, de Vries B, Malik R, Kallela M, Terwindt GM, Pozo-Rosich P, Winsvold B, Nyholt DR, van Oosterhout WP, Artto V, Todt U, Hämäläinen E, Fernández-Morales J, Louter MA, Kaunisto MA, Schoenen J, Raitakari O, Lehtimäki T, Vila-Pueyo M, Göbel H, Wichmann E, Sintas C, Uitterlinden AG, Hofman A, Rivadeneira F, Heinze A, Tronvik E, van Duijn CM, Kaprio J, Cormand B, Wessman M, Frants RR, Meitinger T, Müller-Myhsok B, Zwart JA, Färkkilä M, Macaya A, Ferrari MD, Kubisch C, Palotie A*, Dichgans M*, van den Maagdenberg AM*; International Headache Genetics Consortium. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 44:777-82 (2012) (*shared last-authorship)
    • The International Stroke Genetics Consortium (ISGC); the Wellcome Trust Case Control Consortium 2 (WTCCC2). Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 44:328-33 (2012)
    • Duering M, Zieren N, Hervé D, Jouvent E, Peters N, Pachai C, Opherk C, Chabriat C, Dichgans M. .Strategic Role of Frontal White Matter Tracts in Vascular Cognitive Impairment: A Voxel-Based Lesion-Symptom Mapping Study in CADASIL. Brain 134:2366-75 (2011)
    • Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat H. Donepezil in Patients with Subcortical Vascular Cognitive Impairment: a randomized double-blind trial in CADASIL. Lancet Neurol 7:310-8 (2008)
    • Dichgans M, Freilinger F, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, Ferrari M, Herzog J, van den Maagdenberg AMJM, Pusch M, Strom TM. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371-7 (2005)

Responsible for content: Prof. Dr. Martin Dichgans